Amazon is reportedly mulling on expanding its business in Japan and entering the prescription drug market there. The e-commerce and tech firm is said to be planning to team up with small to mid-sized pharmacies for the project.
According to Nikkei Asia, some sources who are familiar with the project shared that Amazon may launch a new prescription service through partnerships with the local pharmacies in the Asian nation. They added that this is likely to be established starting next year when electronic prescriptions are set to be allowed in Japan for the first time.
The sources opined that if Amazon pushes through with this plan of jumping into the prescription drug sales business, this move could be a turning point for the local brick-and-mortar pharmacies in Japan.
This is because, with the application of Amazon’s cutting-edge ordering and distribution system, customers in the country will be able to have their medicines delivered right on the steps of their homes instead of going out to buy them in pharmacy stores.
To operate the business, Amazon will join forces with local pharmacies and set up a platform where patients can find instructions online - on how to take their medications. In any case, the prices of prescription drugs in Japan are usually set by the government, while the distribution system is in shambles since there are 70 wholesalers across the country, and the number of pharmacies has already reached 60,000.
Thus, if Amazon will enter the country’s prescription drug market, it will be able to offer a more organized distribution system as well. This means that patients and consumers will be able to receive their medicines in a timely and orderly manner.
Meanwhile, Fox Business further reported that the new prescription service may be launched next year and through Amazon, pharmacies in Japan will be able to sell medicines directly to patients online since Japan will start allowing electronic prescriptions in the country by that time. People may obtain virtual prescriptions on Amazon’s platform after receiving professional medical care online.


SMIC Shares Rally as Q2 Profit Surges 262% on Strong Chip Demand
Alibaba Sells Lingxi Games for Over $1.5 Billion Amid AI Push
Malaysia Inflation Eases to 1.8% in July, Below Forecast
AstraZeneca Halts Phase III Volrustomig Lung Cancer Trial After Efficacy Setback
Trump Imposes New US Tariffs on Drone Imports Over National Security Concerns
S&P 500 Retreats From Record High as AI Stocks Slide, Retail Sales Disappoint
Goldman Sachs Eyes Investors for Nvidia’s $500 Billion AI Financing Plan
J.P. Morgan Upgrades SanDisk, Sets $2,250 Price Target on AI NAND Growth
Gold Prices Retreat From Two-Month High as Softer Inflation Eases Fed Rate Hike Bets
US Dollar Slips as Weak Retail Sales Reduce Fed Rate Hike Bets
S&P 500 Hits Record High as Soft Inflation Data Eases Fed Rate Hike Fears
Aviva First-Half Operating Profit Jumps 24% as Direct Line Deal Boosts Growth
Paramount Skydance Clears Regulatory Hurdles for Warner Bros. Discovery Deal
Morgan Stanley Sees Fed Holding Rates as U.S. Inflation Cools
Asian Stocks Steady as Iran War Keeps Oil Prices and Inflation Risks Elevated
Micron Stock Upgraded to Buy as New Street Sees $2 Trillion Valuation Potential
Asian Currencies Edge Higher as Soft US Inflation Weighs on Dollar 



